A detailed history of Wellington Management Group LLP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 4,953,347 shares of ALNY stock, worth $1.2 Billion. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,953,347
Previous 6,210,479 20.24%
Holding current value
$1.2 Billion
Previous $1.51 Billion 9.71%
% of portfolio
0.24%
Previous 0.28%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$233.81 - $287.01 $294 Million - $361 Million
-1,257,132 Reduced 20.24%
4,953,347 $1.36 Billion
Q2 2024

Aug 13, 2024

SELL
$143.31 - $247.0 $143 Million - $247 Million
-998,526 Reduced 13.85%
6,210,479 $1.51 Billion
Q1 2024

May 15, 2024

BUY
$146.51 - $198.2 $1.06 Billion - $1.43 Billion
7,209,005 New
7,209,005 $1.08 Billion
Q4 2023

Feb 12, 2024

BUY
$151.41 - $196.57 $1.09 Billion - $1.42 Billion
7,214,198 New
7,214,198 $1.38 Billion
Q3 2023

Nov 14, 2023

BUY
$170.77 - $211.65 $62.2 Million - $77 Million
364,021 Added 6.0%
6,431,814 $1.14 Billion
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $15.9 Million - $18.2 Million
-85,984 Reduced 1.4%
6,067,793 $1.15 Billion
Q1 2023

May 12, 2023

SELL
$182.66 - $235.53 $14.7 Million - $18.9 Million
-80,309 Reduced 1.29%
6,153,777 $1.23 Billion
Q4 2022

Feb 13, 2023

BUY
$185.53 - $241.31 $51.9 Million - $67.5 Million
279,793 Added 4.7%
6,234,086 $1.48 Billion
Q3 2022

Nov 14, 2022

BUY
$138.54 - $232.0 $19.6 Million - $32.8 Million
141,423 Added 2.43%
5,954,293 $1.19 Billion
Q2 2022

Aug 15, 2022

SELL
$120.42 - $169.29 $147 Million - $207 Million
-1,221,617 Reduced 17.37%
5,812,870 $848 Million
Q1 2022

May 16, 2022

BUY
$127.18 - $173.91 $24.2 Million - $33.1 Million
190,057 Added 2.78%
7,034,487 $1.15 Billion
Q4 2021

Feb 11, 2022

SELL
$159.56 - $209.29 $84 Million - $110 Million
-526,642 Reduced 7.14%
6,844,430 $1.16 Billion
Q3 2021

Nov 15, 2021

SELL
$169.75 - $207.73 $307 Million - $375 Million
-1,807,417 Reduced 19.69%
7,371,072 $1.39 Billion
Q2 2021

Aug 16, 2021

BUY
$128.63 - $176.89 $3.93 Million - $5.4 Million
30,539 Added 0.33%
9,178,489 $1.56 Billion
Q1 2021

May 17, 2021

SELL
$126.83 - $175.69 $115 Million - $160 Million
-908,990 Reduced 9.04%
9,147,950 $1.29 Billion
Q4 2020

Feb 12, 2021

SELL
$122.97 - $147.0 $9.91 Million - $11.8 Million
-80,586 Reduced 0.79%
10,056,940 $1.31 Billion
Q3 2020

Nov 16, 2020

SELL
$121.19 - $165.49 $40.5 Million - $55.3 Million
-334,201 Reduced 3.19%
10,137,526 $1.48 Billion
Q2 2020

Aug 14, 2020

SELL
$104.21 - $156.44 $189 Million - $284 Million
-1,815,051 Reduced 14.77%
10,471,727 $1.55 Billion
Q1 2020

May 14, 2020

SELL
$93.12 - $133.99 $186 Million - $268 Million
-1,999,696 Reduced 14.0%
12,286,778 $1.34 Billion
Q4 2019

Feb 11, 2020

BUY
$74.51 - $124.23 $1.06 Billion - $1.77 Billion
14,286,474 New
14,286,474 $1.65 Billion

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.